Moreover, in the context of diabetes—a metabolic disorder marked by impaired glucose, lipid, and protein metabolisms due to insufficient insulin production and islet cell dysfunction—PVA hydrogels modified with glycerol have shown promise for prolonged insulin release [29,30]. This evidence concerns the gene INS and metabolic disease.